CZ20012544A3 - Farmaceutické balení - Google Patents
Farmaceutické balení Download PDFInfo
- Publication number
- CZ20012544A3 CZ20012544A3 CZ20012544A CZ20012544A CZ20012544A3 CZ 20012544 A3 CZ20012544 A3 CZ 20012544A3 CZ 20012544 A CZ20012544 A CZ 20012544A CZ 20012544 A CZ20012544 A CZ 20012544A CZ 20012544 A3 CZ20012544 A3 CZ 20012544A3
- Authority
- CZ
- Czechia
- Prior art keywords
- hepatitis
- pharmaceutical package
- virus
- package according
- vaccine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9900630 | 1999-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ20012544A3 true CZ20012544A3 (cs) | 2002-01-16 |
Family
ID=10845878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ20012544A CZ20012544A3 (cs) | 1999-01-12 | 1999-12-21 | Farmaceutické balení |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1140163A2 (ko) |
JP (1) | JP2002534438A (ko) |
KR (1) | KR20010090011A (ko) |
CN (1) | CN1391482A (ko) |
AR (1) | AR022250A1 (ko) |
AU (1) | AU760574B2 (ko) |
BR (1) | BR9916893A (ko) |
CA (1) | CA2359110A1 (ko) |
CO (1) | CO5241355A1 (ko) |
CZ (1) | CZ20012544A3 (ko) |
HK (1) | HK1041434A1 (ko) |
HU (1) | HUP0105070A2 (ko) |
IL (1) | IL144186A0 (ko) |
NO (1) | NO20013337L (ko) |
NZ (1) | NZ512890A (ko) |
PL (1) | PL349347A1 (ko) |
TR (1) | TR200102024T2 (ko) |
WO (1) | WO2000041463A2 (ko) |
ZA (1) | ZA200105690B (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
AU4932199A (en) | 1998-07-31 | 2000-02-21 | Haruo Sugiyama | Cancer antigens based on tumor suppressor gene wt1 product |
US20040097703A1 (en) | 2001-03-22 | 2004-05-20 | Haruo Sugiyama | Wt1 modified peptide |
US20050002951A1 (en) * | 2001-09-28 | 2005-01-06 | Haruo Sugiyama | Novel method of inducing antigen-specific t cells |
US8735357B2 (en) | 2001-09-28 | 2014-05-27 | International Institute Of Cancer Immunology, Inc. | Method of inducing antigen-specific T cells |
TWI275392B (en) * | 2002-04-08 | 2007-03-11 | Bristol Myers Squibb Co | Low dose liquid entecavir formulations and use |
PT2241325E (pt) | 2002-10-29 | 2012-04-12 | Coley Pharm Gmbh | Utilização de oligonucleótidos cpg no tratamento de infecção com vírus da hepatite c |
WO2004053104A2 (en) | 2002-12-11 | 2004-06-24 | Coley Pharmaceutical Group, Inc. | 5’ cpg nucleic acids and methods of use |
CN100443117C (zh) * | 2003-05-13 | 2008-12-17 | 深圳康泰生物制品股份有限公司 | 一种治疗性乙型肝炎的疫苗制剂、其制备方法及其用途 |
US8541167B2 (en) | 2004-06-03 | 2013-09-24 | Saint Louis University | Methods and compositions for vaccination |
AR065504A1 (es) * | 2007-02-28 | 2009-06-10 | Ct Ingenieria Genetica Biotech | Terapia combinada para el tratamiento de la hepatitis b cronica. uso. |
WO2020134682A1 (zh) * | 2018-12-24 | 2020-07-02 | 南京远大赛威信生物医药有限公司 | 用于治疗乙型肝炎的药物制剂及其制备方法和用途 |
CN117120088A (zh) * | 2021-04-07 | 2023-11-24 | 电化株式会社 | 佐剂活性增强剂和佐剂组合物 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE159031T1 (de) * | 1989-07-25 | 1997-10-15 | Smithkline Biolog | Antigene sowie verfahren zu deren herstellung |
ES2273482T3 (es) * | 1998-03-09 | 2007-05-01 | Glaxosmithkline Biologicals S.A. | Composiciones de vacunas combinadas. |
-
1999
- 1999-12-21 TR TR2001/02024T patent/TR200102024T2/xx unknown
- 1999-12-21 HU HU0105070A patent/HUP0105070A2/hu unknown
- 1999-12-21 IL IL14418699A patent/IL144186A0/xx unknown
- 1999-12-21 WO PCT/EP1999/010295 patent/WO2000041463A2/en not_active Application Discontinuation
- 1999-12-21 CN CN99816471A patent/CN1391482A/zh active Pending
- 1999-12-21 AU AU21009/00A patent/AU760574B2/en not_active Ceased
- 1999-12-21 EP EP99965531A patent/EP1140163A2/en not_active Withdrawn
- 1999-12-21 BR BR9916893-6A patent/BR9916893A/pt not_active IP Right Cessation
- 1999-12-21 KR KR1020017008833A patent/KR20010090011A/ko not_active Application Discontinuation
- 1999-12-21 NZ NZ512890A patent/NZ512890A/en unknown
- 1999-12-21 CZ CZ20012544A patent/CZ20012544A3/cs unknown
- 1999-12-21 JP JP2000593088A patent/JP2002534438A/ja active Pending
- 1999-12-21 CA CA002359110A patent/CA2359110A1/en not_active Abandoned
- 1999-12-21 PL PL99349347A patent/PL349347A1/xx not_active Application Discontinuation
-
2000
- 2000-01-11 AR ARP000100107A patent/AR022250A1/es not_active Application Discontinuation
- 2000-01-12 CO CO00001261A patent/CO5241355A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 NO NO20013337A patent/NO20013337L/no not_active Application Discontinuation
- 2001-07-11 ZA ZA200105690A patent/ZA200105690B/xx unknown
-
2002
- 2002-02-19 HK HK02101211.9A patent/HK1041434A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
IL144186A0 (en) | 2002-05-23 |
HUP0105070A2 (hu) | 2002-04-29 |
WO2000041463A3 (en) | 2000-11-09 |
NO20013337L (no) | 2001-08-17 |
NZ512890A (en) | 2003-09-26 |
KR20010090011A (ko) | 2001-10-17 |
TR200102024T2 (tr) | 2001-12-21 |
PL349347A1 (en) | 2002-07-15 |
JP2002534438A (ja) | 2002-10-15 |
NO20013337D0 (no) | 2001-07-05 |
WO2000041463A2 (en) | 2000-07-20 |
CN1391482A (zh) | 2003-01-15 |
ZA200105690B (en) | 2002-09-25 |
AU2100900A (en) | 2000-08-01 |
AU760574B2 (en) | 2003-05-15 |
EP1140163A2 (en) | 2001-10-10 |
CO5241355A1 (es) | 2003-01-31 |
AR022250A1 (es) | 2002-09-04 |
CA2359110A1 (en) | 2000-07-20 |
HK1041434A1 (zh) | 2002-07-12 |
BR9916893A (pt) | 2001-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2247605B1 (en) | Hydrophobic modified preS-derived peptides of hepatitis B virus (HBV) and their use as HBV and HDV entry inhibitors | |
CZ20012544A3 (cs) | Farmaceutické balení | |
AU2021200857B2 (en) | Crystalline forms of tenofovir alafenamide | |
US9878035B2 (en) | Hepatitis B vaccine | |
CZ337997A3 (cs) | Prostředek s vakcinačním účinkem a jeho použití pro výrobu vakciny | |
JP2018512428A5 (ko) | ||
WO2015196935A1 (zh) | 含有CpG寡核苷酸的药物组合物 | |
JP2023506439A (ja) | 医薬組成物及びその用途 | |
KR20220119616A (ko) | Tlr7 효현제를 이용하여 바이러스 감염을 치료하는 방법 | |
EP1284720B1 (en) | L-fmau for the treatment of hepatitis delta viral infection | |
KR20070110513A (ko) | 알루미늄 포스페이트 및 3d-mpl을 포함하는 보조약조성물 | |
WO2004026899A9 (fr) | Immunogene permettant de preparer des vaccins ou des medicaments therapeutiques pour traiter l'hepatite b et son procede de production et d'utilisation | |
US20110059132A1 (en) | Composition for therapy and/or for prophylaxis of hbv-infections and hbv-mediated diseases | |
US9872895B2 (en) | TLR5 ligands, therapeutic methods, and compositions related thereto | |
WO2003037265A2 (en) | Method of treating viral infections | |
KR20210151047A (ko) | B형 간염 치료를 위한 면역원성 조성물 | |
MXPA01007112A (en) | Novel treatment | |
JP2022516041A (ja) | B型肝炎を治療するための薬物製剤、その製造方法及び用途 | |
US7144703B2 (en) | Composition | |
AU2010339417A1 (en) | Compositions and methods for treating hepatitis B virus infection | |
TW201735945A (zh) | 包括b型肝炎病毒之表面及核殼體抗原的藥學組成物 | |
TWI311563B (en) | Method for production a stable,immunogenic hepatitis b vaccine without trace of thiomersal | |
NZ705184B2 (en) | Yeast-based therapeutic for chronic hepatitis b infection |